Canada Life’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-86
| Closed | -$4K | – | 2222 |
|
|
2023
Q3 | $4K | Hold |
86
| – | – | ﹤0.01% | 2229 |
|
|
2023
Q2 | $7K | Hold |
86
| – | – | ﹤0.01% | 2249 |
|
|
2023
Q1 | $8K | Hold |
86
| – | – | ﹤0.01% | 2303 |
|
|
2022
Q4 | $10K | Hold |
86
| – | – | ﹤0.01% | 2327 |
|
|
2022
Q3 | $16K | Hold |
86
| – | – | ﹤0.01% | 2291 |
|
|
2022
Q2 | $8K | Hold |
86
| – | – | ﹤0.01% | 2389 |
|
|
2022
Q1 | $14K | Hold |
86
| – | – | ﹤0.01% | 2404 |
|
|
2021
Q4 | $25K | Hold |
86
| – | – | ﹤0.01% | 2336 |
|
|
2021
Q3 | $50K | Hold |
86
| – | – | ﹤0.01% | 2237 |
|
|
2021
Q2 | $39K | Buy |
86
+46
| +115% | +$20.9K | ﹤0.01% | 2339 |
|
|
2021
Q1 | $21K | Hold |
40
| – | – | ﹤0.01% | 2501 |
|
|
2020
Q4 | $35K | Buy |
+40
| New | +$35K | ﹤0.01% | 2401 |
|